About this trial
At Uppsala University Hospital, there is an outpatient clinic for women subjected to intimate partner violence. In order to explore how patients experience the biopsychosocial resilience-based intervention in use at the clinic and how well the intervention fits the needs of the patients, 30 patients from different stages of their contact at the clinic and with diverse life situations and background are enrolled. The researchers will carry out individual in-person interviews, each lasting approximately 60 minutes, based on a semi-structured set of questions. The questions concern the participant´s life situation, resilience and self-perceived needs, how well the intervention has met those needs and how it was perceived by the participant. The interviews are audio-recorded and transcribed verbatim for thematic analysis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Enrolled in the EMBER intervention at the NCK outpatient clinic.
Disqualifiers
Any situation that, in the opinion of the Investigator, would compromise the safety of the patient or the quality of the data.
Trial population
The participants are patients at the NCK outpatient clinic at Uppsala University Hospital, due to experiences of being subjected to intimate partner violence. Due to clinic admission criteria, the population is limited to women over 18 of age. Participants are enrolled by strategic sampling to assure a diverse sample across variables of health, age, ethnicity, socio-economy and time enrolled at the clinic.
Trial design
Other
Cross-sectional
Treatments tested in this trial
Qualitative interview
BehavioralA semi-structured interview
Treatment groups
Trial outcomes
Primary outcomes
Patient experiences of EMBER
Interview questions exploring experiences and attitudes regarding the EMBER intervention
Secondary outcomes
Needs and resilience
Interview questions concerning perceptions and beliefs regarding what is needed for recovery after intimate partner violence
Sponsors and contacts
Click on the lead sponsor to view all of their trials.